Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes

Human Molecular Genetics

Volumn 25, Issue 8, 2016, Pages 1543-1558

  Lanciotti, Angela ^a   Brignone, Maria Stefania ^a   Visentin, Sergio ^a   De Nuccio, Chiara ^a   Catacuzzeno, Luigi ^b   Mallozzi, Cinzia ^a   Petrini, Stefania ^c   Caramia, Martino ^b   Veroni, Caterina ^a   Minnone, Gaetana ^c   Bernardo, Antonietta ^a   Franciolini, Fabio ^b   Pessia, Mauro ^b,d   Bertini, Enrico ^c   Petrucci, Tamara Corinna ^a   Ambrosini, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF MALTA   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE C GAMMA1; PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MLC1 MEMBRANE PROTEIN, RAT; MLC1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; ASTROCYTOSIS; BRAIN DEVELOPMENT; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MACROPHAGE; MISSENSE MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; ASTROCYTOMA; CYST; CYTOLOGY; DEMYELINATING DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ASTROCYTES; ASTROCYTOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTS; GENE EXPRESSION REGULATION; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; HUMANS; MEMBRANE PROTEINS; MUTATION; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84963764876     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw032     Document Type: Article

References (87)

1. Sofroniew, M.V. and Vinters, H.V. (2010) Astrocytes: biology and pathology. Acta Neuropathol., 119, 7-35.
2. Brenner, M., Johnson, A.B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J.E. and Messing, A. (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet., 27, 117-120.
3. Leegwater, P.A., Yuan, B.Q., Van Der Steen, J., Mulders, J., Konst, A.A., Boor, P.K., Mejaski-Bosnjak, V., Van Der Maarel, S.M., Frants, R.R., Oudejans, C.B. et al. (2001) Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am. J. Hum. Genet., 68, 831-838.
4. Lanciotti, A., Brignone, M.S., Bertini, E., Petrucci, T.C., Aloisi, F. and Ambrosini, E. (2013) Astrocytes: emerging stars in leukodystrophy pathogenesis. Transl. Neurosci., 4, 1-37.
5. Van der Knaap, M.S., Barth, P.G., Stroink, H., Van Nieuwenhuizen, O., Arts, W.F., Hoogenraad, F. and Valk, J. (1995) Leukoncephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann. Neurol., 7, 324-334.
6. Topku, M., Saatci, I., Topcuoglu, M.A., Kose, G. and Kunak, B. (1998) Megalencephaly and leukodystrophy with mild clinical course: a report on 12 new cases. Brain Dev., 20, 142-153.
7. Ben-Zeev, B., Gross, V., Kushnir, T., Shalev, R., Hoffman, C., Shinar, Y., Pras, E. and Brand, N. (2001) Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J. Child. Neurol., 16, 93-99.
8. Singhal, B.S., Gorospe, J.R. and Naidu, S. (2003) Megalencephalic leukoencephalopathy with subcortical cysts. J. Child. Neurol., 18, 646-652.
9. Bugiani, M., Moroni, I., Bizzi, A., Nardocci, N., Bettecken, T., Gärtner, J. and Uziel, G. (2003) Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts. Neuropediatrics, 34, 211-214.
10. van der Knaap, M.S., Barth, P.G., Vrensen, G.F. and Valk, J. (1996) Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. Acta Neuropathol., 92, 206-212.
11. Pascual-Castroviejo, I., Van der Knaap, M.S., Pronk, J.C., Garcia-Segura, J.M., Gutierez-Molina, M. and Pascual-Pascual, S.I. (2005) Vacuolating megalencephalic leukoencephalopathy: year follow-up of two siblings. Neurologia, 20, 33-40.
12. Duarri, A., de Heredia, M.L., Capdevila-Nortes, X., Ridder, M.C., Montolio, M., Lopez-Hernandez, T., Boor, I., Lien, C.F., Hagemann, T., Messing, A. et al. (2011) Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model. Neurobiol. Dis., 43, 228-238.
13. Leegwater, P.A., Boor, P.K., Yuan, B.Q., van der Steen, J., Visser, A., Konst, A.A., Oudejans, C.B., Schutgens, R.B., Pronk, J.C. and van der Knaap, M.S. (2002) Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts. Hum. Genet., 110, 279-283.
14. Patrono, C., Di Giacinto, G., Eymard-Pierre, E., Santorelli, F.M., Rodriguez, D., De Stefano, N., Federico, A., Gatti, R., Benigno, V., Megarbané, A. et al. (2003) Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts. Neurology, 61, 534-537.
15. Boor, P.K.I.,deGroot,K.,Mejaski-Bosnjak,V.,Brenner,C., vander Knaap,M.S.,Scheper,G.C.andPronk, J.C. (2006)Megalencephalic leukoencephalopathywith subcortical cysts: an update and extendedmutation analysis ofMLC1. Hum. Mutat., 27, 505-512.
16. Teijido, O., Casaroli-Marano, R., Kharkovets, T., Aguado, F., Zorzano, A., Palacín, M., Soriano, E., Martínez, A. and Estévez, R. (2007) Expression patterns of MLC1 protein in the central and peripheral nervous systems. Neurobiol. Dis., 26, 532-545.
17. Teijido, O., Martinez, A., Pusch, M., Zorzano, A., Soriano, E., Del Rio, J.A., Palacin, M. and Estevez, R. (2004) Localization and functional analyses of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts. Hum. Mol. Genet., 13, 2581-2594.
18. Boor, P.K.I., DeGroot, K., Waisfisz, Q., Kamphrost, W., Oudejans, C.B.M., Powers, J.M., Pronk, J.C., Shepert, G.C. and van der Knaap, M.S. (2005) MLC1 a novel protein in distal astroglial processes. J. Neuropathol. Exp. Neurol., 64, 412-419.
19. Brignone, M.S., Lanciotti, A., Camerini, S., De Nuccio, C., Petrucci, T.C., Visentin, S. and Ambrosini, E. (2015) MLC1 protein: a likely link between leukodystrophies and brain channelopathies. Front. Cell. Neurosci., 9, 66.
20. Lanciotti, A., Brignone, M.S., Camerini, S., Serafini, B., Macchia, G., Raggi, C., Molinari, P., Crescenzi, M., Musumeci, M., Sargiacomo, M. et al. (2010) MLC1 trafficking and membrane expression in astrocytes: role of caveolin-1 and phosphorylation. Neurobiol. Dis., 37, 581-595.
21. Schmitt, A., Gofferje, V.,Weber, M., Meyer, J., Mössner, R. and Lesch, K.P. (2003) The brain-specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain. Glia, 44, 283-295.
22. Ambrosini, E., Serafini, B., Lanciotti, A., Tosini, F., Scialpi, F., Psaila, R., Di Girolamo, F., Petrucci, T.C. and Aloisi, F. (2008) Biochemical characterization of MLC1 protein in astrocytes and its association with the dystrophin-glycoprotein complex. Mol. Cell. Neurosci., 37, 480-493.
23. Dubey, M., Bugiani,M., Ridder,M.C., Postma,N.L., Brouwers, E., Polder, E., Jacobs, J.G., Baayen, J.C., Klooster, J. and Kamermans, M. (2015) Mice with megalencephalic leukoencephalopathy with cysts: a developmental angle. Ann. Neurol., 77, 114-131.
24. Ridder, M.C., Boor, I., Lodder, J.C., Postma, N.L., Capdevila- Nortes, X., Duarri, A., Brussaard, A.B., Estévez, R., Scheper, G.C., Mansvelder, H.D. and van der Knaap, M.S. (2011) Megalencephalic leucoencephalopathy with cysts: defect in chloride currents and cell volume regulation. Brain, 134, 3342-3354.
25. Lanciotti, A., Brignone, M.S., Molinari, P., Visentin, S., De Nuccio, C., Macchia, G., Aiello, C., Bertini, E., Aloisi, F., Petrucci, T.C. and Ambrosini, E. (2012) Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations. Hum. Mol. Genet., 21, 2166-2180.
26. Brignone, M.S., Lanciotti, A., Macioce, P.,Macchia, G., Gaetani, M., Aloisi, F., Petrucci, T.C. and Ambrosini, E. (2011) The beta1 subunit of the na,K-ATPase pump interacts with megalencephalic leucoencephalopathy with subcortical cysts protein 1 (MLC1) in brain astrocytes: new insights into MLC pathogenesis. Hum. Mol. Genet., 20, 90-103.
27. Brignone, M.S., Lanciotti, A., Visentin, S., De Nuccio, C., Molinari, P., Camerini, S., Diociaiuti, M., Petrini, S., Minnone, G., Crescenzi, M. et al. (2014) Megalencephalic leukoencephalopathy with subcortical cysts protein-1 modulates endosomal pH and protein trafficking in astrocytes: relevance to MLC disease pathogenesis. Neurobiol. Dis., 66, 1-18.
28. Hoegg-Beiler,M.B., Sirisi, S., Orozco, I.J., Ferrer, I., Hohensee, S., Auberson, M., Gödde, K., Vilches, C., de Heredia, M.L., Nunes, V., Estévez, R. and Jentsch, T.J. (2014) Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction. Nat. Commun., 5, 3475.
29. Lang, F., Föller, M., Lang, K., Lang, P., Ritter, M., Vereninov, A., Szabo, I., Huber, S.M. and Gulbins, E. (2007) Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol., 428, 209-225.
30. Molofsky, A.V., Krencik, R., Ullian, E.M., Tsai, H.H., Deneen, B., Richardson,W.D., Barres, B.A. and Rowitch, D.H. (2012) Astrocytes and disease: a neurodevelopmental perspective. Genes. Dev., 26, 891-907.
31. Yang, Y., Higashimori, H. and Morel, L. (2013) Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders. J. Neurodev. Disord., 5, 22.
32. Kang, C.S., Zhang, Z.Y., Jia, Z.F., Wang, G.X., Qiu, M.Z., Zhou, H.X., Yu, S.Z., Chang, J., Jiang, H. and Pu, P.Y. (2006) Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther., 13, 530-538.
33. Chakraborty, S., Li, L., Puliyappadamba, V.T., Guo, G., Hatanpaa, K.J., Mickey, B., Souza, R.F., Vo, P., Herz, J., Chen, M.R. et al. (2014) Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks. Nat. Commun., 5, 5811.
34. Ceresa, B.P. (2011) Endocytic Trafficking of the Epidermal Growth Factor Receptor in Transformed Cells. Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways. Book edited by Mehmet Gunduz and Esra Gunduz, ISBN 978-953- 307-714-7.
35. Sorkin, A. and Goh, L.K. (2008) Endocytosis and intracellular trafficking of ErbBs. Exp. Cell. Res., 314, 3093-3106.
36. Jones, S. and Rappoport, J.Z. (2014) Interdependent epidermal growth factor receptor signalling and trafficking. Int. J. Biochem. Cell. Biol., 5, 23-28.
37. Ambrosini, E., Sicca, F., Brignone, M.S., D'Adamo, M.C., Napolitano, C., Servettini, I., Moro, F., Ruan, Y., Guglielmi, L., Pieroni, S. et al. (2014) Genetically induced dysfunctions of Kir2.1 channels: implications for short QT3 syndrome and autismepilepsy phenotype. Hum. Mol. Genet., 23, 4875-4886.
38. Gao,W.L., Tian, F., Zhang, S.Q., Zhang, H. and Yin, Z.S. (2014) Epidermal growth factor increases the expression of Nestin in rat reactive astrocytes through the Ras-Raf-ERK pathway. Neurosci. Lett., 562, 54-59.
39. Guéguinou, M., Gambade, A., Félix, R., Chantôme, A., Fourbon, Y., Bougnoux, P., Weber, G., Potier-Cartereau, M. and Vandier, C. (2015) Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: novel targets to reduce tumor development by lipids? Biochim. Biophys. Acta, 1848, 2603-2620.
40. Balbis, A. and Posner, B.I. (2010) Compartmentalization of EGFR in cellular membranes: role of membrane rafts. J. Cell. Biochem., 109, 1103-1108.
41. Petrini, S., Minnone, G., Coccetti, M., Frank, C., Aiello, C., Cutarelli, A., Ambrosini, E., Lanciotti, A., Brignone, M.S., D'Oria, V. et al. (2013) Monocytes and macrophages as biomarkers for the diagnosis of megalencephalic leukoencephalopathy with subcortical cysts. Mol. Cell. Neurosci., 356, 307-321.
42. Lamb, D.J., Modjtahedi, H., Plant, N.J. and Ferns, G.A. (2004) EGF mediates monocyte chemotaxis andmacrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis, 176, 21-26.
43. Bryant, J.A., Finn, R.S., Slamon, D.J., Cloughesy, T.F. and Charles, A.C. (2004) EGF activates intracellular and intercellular calcium signaling by distinct pathways in tumor cells. Cancer. Biol. Ther., 3, 1243-1249.
44. Tajeddine, N. and Gailly, P. (2012) TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling. J. Biol. Chem., 287, 16146-16157.
45. Mendoza, M.C., Er, E.E. and Blenis, J. (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci., 36, 320-328.
46. Puschmann, T.B., Zandén, C., Lebkuechner, I., Philippot, C., de Pablo, Y., Liu, J. and Pekny, M. (2014) HB-EGF affects astrocyte morphology, proliferation, differentiation, and the expression of intermediate filament proteins. J. Neurochem., 128, 878-889.
47. Longden, T.A., Dunn, K.M., Draheim, H.J., Nelson, M.T., Weston, A.H. and Edwards, G. (2011) Intermediate-conductance calcium-activated potassium channels participate in neurovascular coupling. Br J Pharmacol., 164, 922-933.
48. Fioretti, B., Castigli, E., Micheli, M.R., Bova, R., Sciaccaluga, M., Harper, A., Franciolini, F. and Catacuzzeno, L. (2006) Expression and modulation of the intermediate- conductance Ca2+-activated K+ channel in glioblastoma GL-15 cells. Cell. Physiol. Biochem., 18, 47-56.
49. Fioretti, B., Catacuzzeno, L., Sforna, L., Aiello, F., Pagani, F., Ragozzino, D., Castigli, E. and Franciolini, F. (2009) Histamine hyperpolarizes human glioblastoma cells by activating the intermediate-conductance Ca2+- activated K+ channel. Am. J. Physiol. Cell. Physiol., 297, C102-C110.
50. Bouhy, D., Ghasemlou, N., Lively, S., Redensek, A., Rathore, K. I., Schlichter, L.C. and David, S. (2011) Inhibition of the Ca2+ dependent K+ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury. J. Neurosci., 31, 16298-16308.
51. Ruggieri, P., Mangino, G., Fioretti, B., Catacuzzeno, L., Puca, R., Ponti, D., Miscusi, M., Franciolini, F., Ragona, G. and Calogero, A. (2012) The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells. PLoS One, 7, e47825.
52. D'Alessandro, G., Catalano, M., Sciaccaluga, M., Chece, G., Cipriani, R., Rosito, M., Grimaldi, A., Lauro, C., Cantore, G., Santoro, A. et al. (2013) KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell. Death Dis., 4, e773.
53. Tomas, A., Futter, C.E. and Eden, E.R. (2014) EGF receptor trafficking: consequences for signaling and cancer. Trends Cell. Biol., 24, 26-34.
54. Runkle, K.B., Meyerkord, C.L., Desai, N.V., Takahashi, Y. and Wang, H.G. (2012) Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation. Cancer Biol. Ther., 13, 956-966.
55. Diering, G.H., Numata, Y., Fan, S., Church, J. and Numata, M. (2013) Endosomal acidification by Na+/H+ exchanger NHE5 regulates TrkA cell-surface targeting and NGF-induced PI3K signaling. Mol. Biol. Cell., 24, 3435-3448.
56. Hanafusa, H., Ishikawa, K., Kedashiro, S., Saigo, T., Iemura, S., Natsume, T., Komada, M., Shibuya, H., Nara, A. andMatsumoto, K. (2011) Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor. Nat. Commu., 2, 158.
57. Sigismund, S., Argenzio, E., Tosoni, D., Cavallaro, E., Polo, S. and Di Fiore, P.P. (2008) Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev. Cell., 15, 209-219.
58. Brambilla, R., Neary, J.T., Cattabeni, F., Cottini, L., D'Ippolito, G., Schiller, P.C. and Abbracchio, M.P. (2002) Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J. Neurochem., 83, 1285-1296.
59. Neary, J.T., Kang, Y.,Willoughby, K.A. and Ellis, E.F. (2003) Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J. Neurosci., 23, 2348-2356.
60. Ito, M., Natsume, A., Takeuchi, H., Shimato, S., Ohno, M.,Wakabayashi, T. and Yoshida, J. (2009) Type I interferon inhibits astrocytic gliosis and promotes functional recovery after spinal cord injury by deactivation of the MEK/ERK pathway. J. Neurotrauma, 26, 41-53.
61. Tilly, B.C., van den Berghe, N., Tertoolen, L.G., Edixhoven, M.J. and de Jonge, H.R. (1993) Protein tyrosine phosphorylation is involved in osmoregulation of ionic conductances. J. Biol. Chem., 268, 19919-19922.
62. Ren, Z. and Baumgarten, C.M. (2005) Antagonistic regulation of swelling-activated Cl- current in rabbit ventricle by Src and EGFR protein tyrosine kinases. Am. J. Physiol. Heart Circ. Physiol., 288, H2628-H2636.
63. Lezama, R., Díaz-Téllez, A., Ramos-Mandujano, G., Oropeza, L. and Pasantes-Morales, H. (2005) Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions. Neurochem. Res., 30, 1589-1597.
64. Franco, R., Lezama, R., Ordaz, B. and Pasantes-Morales, H. (2004) Epidermal growth factor receptor is activated by hyposmolarity and is an early signal modulating osmolyte efflux pathways in Swiss 3T3 fibroblasts. Pflugers Arch., 447, 830-839.
65. Cai, L., Du, T., Song, D., Li, B., Hertz, L. and Peng, L. (2011) Astrocyte ERK phosphorylation precedes K(+)-induced swelling but follows hypotonicity-induced swelling. Neuropathology, 31, 250-264.
66. Varela, D., Simon, F., Olivero, P., Armisén, R., Leiva-Salcedo, E., Jørgensen, F., Sala, F. and Stutzin, A. (2007) Activation of H2O2-induced VSOR Cl-currents in HTC cells require phospholipase C gamma1 phosphorylation and Ca2+ mobilisation. Cell. Physiol. Biochem., 20, 773-780.
67. Xia, X.M., Fakler, B., Rivard, A.,Wayman, G., Johnson-Pais, T., Keen, J.E., Ishii, T., Hirschberg, B., Bond, C.T., Lutsenko, S., Maylie, J. and Adelman, J.P. (1998) Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature, 395, 503-507.
68. Khanna, R., Chang, M.C., Joiner, W.J., Kaczmarek, L.K. and Schlichter, L.C. (1999) hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J. Biol. Chem., 274, 14838-14849.
69. Ghanshani, S., Wulff, H., Miller, M.J., Rohm, H., Neben, A., Gutman, G.A., Cahalan, M.D. and Chandy, K.G. (2000) Upregulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem., 275, 37137-37149.
70. Yu, Z., Yu, P., Chen, H. and Geller, H.M. (2014) Targeted inhibition of KCa3.1 attenuates TGF-ß-induced reactive astrogliosis through the Smad2/3 signaling pathway. J. Neurochem., 130, 41-49.
71. Liu, B., Chen, H., Johns, T.G. and Neufeld, A.H. (2006) Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J. Neurosci., 26, 7532-7540.
72. Liu, B. and Neufeld, A.H. (2007) Activation of epidermal growth factor receptors in astrocytes: from development to neural injury. J. Neurosci. Res., 85, 3523-3529.
73. Dietrich, J., Lacagnina, M., Gass, D., Richfield, E., Mayer- Pröschel, M., Noble, M., Torres, C. and Pröschel, C. (2005) EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishingwhitematter leukodystrophy. Nat. Med., 11, 277-283.
74. Hussaini, I.M., Brown, M.D., Karns, L.R., Carpenter, J., Redpath, G.T., Gonias, L. and Vandenberg, S.R. (1999) Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia, 25, 71-84.
75. Lopez-Hernandez, T., Ridder, M.C., Montolio, M., Capdevila- Nortes, X., Polder, E., Sirisi, S., Duarri, A., Schulte, U., Fakler, B., Nunes, V. et al. (2011) Mutant GlialCAMcauses megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am. J. Hum. Genet., 88, 422-432.
76. Zhang, Q.L., Luo, C.L.,Wu, X.H.,Wang, C.Y., Xu, X., Zhang, Y.Y., Liu, Q. and Shen, S.L. (2011) HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma. J. Cell. Biochem., 112, 2910-2919.
77. Jiang, X.L., Zhang, Y., Tan, B., Luo, C.L. and Wu, X.H. (2014) Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner. Neoplasma, 61, 416-423.
78. Burda, J.E. and Sofroniew, M.V. (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron, 81, 229-248.
79. Pekny, M.,Wilhelmsson, U. and Pekna, M. (2014) The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett., 565, 30-568.
80. Codeluppim, S., Svensson, C.I., Hefferan, M.P., Valencia, F., Silldorff, M.D., Oshiro, M., Marsala, M. and Pasquale, E.B. (2009) The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord. J. Neurosci., 29, 1093-1104.
81. Zhang, X. and Neufeld, A.H. (2007) Signal transduction pathways for epidermal growth factor stimulated cyclooxygenase-induction in astrocytes. Exp. Eye Res., 85, 280-288.
82. Xia, M. and Zhu, Y. (2011) Signaling pathways of ATP-induced PGE2 release in spinal cord astrocytes are EGFR transactivation- dependent. Glia, 59, 664-674.
83. Dai,H., Song, D.,Xu, J., Li, B.,Hertz, L. and Peng, L. (2013)Ammonia- induced Na,K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling. Neurochem. Int., 63, 610-625.
84. Yang, J., Li, Q., Zhou, X.D., Kolosov, V.P. and Perelman, J.M. (2011) Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-?B activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol. Cell. Biochem., 351, 29-40.
85. Mauler, F., Hinz, V., Horváth, E., Schuhmacher, J., Hofmann, H.A., Wirtz, S., Hahn, M.G. and Urbahns, K. (2004) Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma. Eur. J. Neurosci., 20, 1761-1768.
86. Chen, Y.J.,Wallace, B.K., Yuen, N., Jenkins, D.P., Wulff, H. and O'Donnell, M.E. (2015) Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke. Stroke, 46, 237-244.
87. Wilson, S.J., Amsler, K., Hyink, D.P., Li, X., Lu,W., Zhou, J., Burrow, C.R. and Wilson, P.D. (2006) Inhibition of HER-2(neu/ ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim. Biophys. Acta, 1762, 647-655.